• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Recent Advances in the Study of 3-Cyclopropyl-1H-pyrazole-5-carbohydrazide (CAS: 395653-63-1)

3-Cyclopropyl-1H-pyrazole-5-carbohydrazide (CAS: 395653-63-1) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. This heterocyclic compound, characterized by its pyrazole core and cyclopropyl substituent, exhibits unique physicochemical properties that make it a promising scaffold for the design of novel therapeutic agents. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules targeting various diseases, including infectious diseases, cancer, and neurological disorders.

A 2023 study published in the Journal of Medicinal Chemistry highlighted the synthesis and biological evaluation of 3-Cyclopropyl-1H-pyrazole-5-carbohydrazide derivatives as potent inhibitors of bacterial enzymes. The researchers demonstrated that modifications to the carbohydrazide moiety could enhance binding affinity to target proteins, leading to improved antimicrobial activity. These findings underscore the compound's versatility as a building block for antimicrobial drug development, particularly in the face of rising antibiotic resistance.

In addition to its antimicrobial potential, 3-Cyclopropyl-1H-pyrazole-5-carbohydrazide has been investigated for its anticancer properties. A recent preprint on bioRxiv reported that certain derivatives of this compound exhibited selective cytotoxicity against cancer cell lines by modulating key signaling pathways involved in apoptosis and cell cycle regulation. The study utilized computational docking and molecular dynamics simulations to elucidate the interactions between the compound and its molecular targets, providing valuable insights for future structure-activity relationship (SAR) studies.

Another area of interest is the compound's application in neurological research. A 2024 paper in ACS Chemical Neuroscience described the synthesis of 3-Cyclopropyl-1H-pyrazole-5-carbohydrazide analogs designed to cross the blood-brain barrier (BBB). Preliminary in vivo studies in rodent models showed promising results in mitigating neuroinflammation, suggesting potential therapeutic utility for neurodegenerative diseases such as Alzheimer's and Parkinson's.

Despite these advancements, challenges remain in optimizing the pharmacokinetic and pharmacodynamic profiles of 3-Cyclopropyl-1H-pyrazole-5-carbohydrazide derivatives. Future research directions may include the development of prodrug strategies to improve bioavailability and the exploration of combination therapies to enhance efficacy. Overall, the growing body of research on this compound highlights its potential as a versatile scaffold in medicinal chemistry, with applications spanning multiple therapeutic areas.

• 262292-02-4(3-tert-butyl-1H-pyrazole-5-carbohydrazide)
• 40535-14-6(5-methyl-1H-pyrazole-3-carbohydrazide)
• 1403333-98-1(5-acetyl-1H-pyrazole-3-carboxamide)
• 957129-50-9(5-butyl-1H-Pyrazole-3-carboxamide)
• 401629-05-8(5-cyclopropyl-1H-Pyrazole-3-carboxamide)
• 957129-48-5(5-propyl-1H-Pyrazole-3-carboxamide)
• 957129-49-6(5-(1-methylethyl)-1H-Pyrazole-3-carboxamide)
• 55508-11-7(5-Ethyl-1H-pyrazole-3-carboxamide)
• 4317-55-9(5-cyclopropyl-N'-(4-methylbenzylidene)-1H-pyrazole-3-carbohydrazide)
• 26275-64-9(1H-Pyrazole-5-carbohydrazide)